These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 27541738)

  • 1. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
    Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
    J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
    Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
    Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
    Bakr RB; Azouz AA; Abdellatif KR
    J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors.
    Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC
    Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
    Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
    Abdelall EKA; Lamie PF; Ali WAM
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme.
    Mohamed LW; Shaaban MA; Zaher AF; Alhamaky SM; Elsahar AM
    Bioorg Chem; 2019 Mar; 83():47-54. PubMed ID: 30342385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects.
    Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT
    Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
    Bakr RB; Ghoneim AA; Azouz AA
    Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles.
    Faidallah HM; Rostom SAF
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.
    Abdellatif KR; Fadaly WA
    Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
    Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
    Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents.
    Abdellatif KRA; Fadaly WAA
    Bioorg Chem; 2017 Jun; 72():123-129. PubMed ID: 28411407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
    Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
    Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
    Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study.
    Lamie PF; Philoppes JN; Azouz AA; Safwat NM
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):805-820. PubMed ID: 28587532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.